ReviewFrontiers in plant science2025
Biochemical evaluation of molecular parts for flavonoid production using plant synthetic biology.
Review in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Widely Targeted Metabolomic Analysis of Metabolic Differences Among Various Organs ofMetabolites · 2026Article
- Oral whole-leaf matcha partially attenuates UV-induced dermoepidermal disruption and collagen phenotype alterations in a rat model of repeated photoaging.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among organisms on Earth, plants have the unique ability to produce a wide variety of biomolecules using soil nutrients, air, and solar energy. Therefore, plants are regarded as the most productive and cost-efficient bioreactors among living organisms. Flavonoids, a major group of secondary metabolites exclusively produced in plants, play crucial roles in plant physiology and have various effects on human health. Flavonoids are used in diverse industries such as the pharmaceutical, nutraceutical, and cosmetics industries. These compounds are typically extracted from specific plants that naturally produce large amounts of the target flavonoid for commercial production. However, with the increasing demand for flavonoids, efforts have been made to enhance flavonoid production using synthetic biology for sustainable production in microbes or plants. Synthetic biology has been utilized for plant metabolic engineering to reconstitute the biosynthetic pathways of target flavonoids at the whole-pathway level, thereby enhancing flavonoid production. For the most efficient flavonoid production using plant synthetic biology, first of all, optimized molecular parts and enzymes must be identified and selected. The best modules to produce the precursors and final target flavonoids can then be constructed using these optimized parts. In this review, we summarize the enzyme kinetics of natural and engineered molecular parts derived from different plant species and provide insight into the selection of molecular parts, design of devices, and reconstitution of pathways based on enzyme performance for sustainable flavonoid production using plant synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.